Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
  2. Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

Company A-Z

Latest Content

Emisphere Development Update

Novo Nordisk has announced the Federal Food and Drug Administration (FDA) approved Rybelsus, a semaglutide tablet, intended for management in type 2 diabetes patients.

November’s top news stories

Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether Jardiance (empagliflozin) improves acute heart failure, and The Janssen Pharmaceutical Companies of Johnson & Johnson is reimagining digital clinical trial design with the launch of a new study. Clinicaltrialsarena.com wraps up key headlines from November 2019.

Latest News

Close
Close
Close

Go Top